S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
pixel
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
pixel
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
pixel
S&P 500   4,544.90
DOW   35,677.02
QQQ   374.10
pixel
NASDAQ:CLMT

Calumet Specialty Products Partners Price Target, Predictions & Analyst Ratings

$11.06
-0.10 (-0.90 %)
(As of 10/22/2021 04:00 PM ET)
Add
Compare
Today's Range
$10.82
$11.39
50-Day Range
$5.74
$10.91
52-Week Range
$2.70
$11.39
Volume109,244 shs
Average Volume181,555 shs
Market Capitalization$870.16 million
P/E RatioN/A
Dividend YieldN/A
Beta2.77

Calumet Specialty Products Partners (NASDAQ:CLMT) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analyst Rating Consensus

Buy
Based on 3 Analyst Ratings

Analyst Price Target Consensus

$13.67

High PT$19.00
Average PT$13.67
Low PT$11.00
TypeCurrent
10/24/20 to 10/24/21
1 Month Ago
9/24/20 to 9/24/21
3 Months Ago
7/26/20 to 7/26/21
1 Year Ago
10/25/19 to 10/24/20
Consensus Rating
Buy
Buy
Buy
Hold
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
1 Buy rating(s)
1 Buy rating(s)
0 Buy rating(s)
Hold
1 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$13.67$8.00$8.00$1.00
Price Target Upside23.57% Upside51.52% Upside51.52% Upside-13.04% Downside
Get Calumet Specialty Products Partners Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CLMT and its competitors with MarketBeat's FREE daily newsletter.


Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Calumet Specialty Products Partners (NASDAQ:CLMT) vs. Its Competitors

TypeCalumet Specialty Products PartnersOils/Energy CompaniesS&P 500
Consensus Rating Score
2.67
2.42
2.56
Consensus RatingBuyHoldBuy
Price Target Upside20.97% Upside6.83% Upside
News Sentiment RatingPositive News
Positive News
Neutral News
MarketBeat
Community Rating
Outperform Votes
291
53.59%
Underperform Votes
252
46.41%
Avg. Outperform Votes
270
65.06%
Avg. Underperform Votes
145
34.94%
Avg. Outperform Votes
831
69.48%
Avg. Underperform Votes
365
30.52%

Calumet Specialty Products Partners (NASDAQ:CLMT) Analyst Ratings History

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/14/2021The Goldman Sachs Group
Carly Davenport
Boost Price TargetNeutral$6.00 ➝ $11.00+0.82%
10/8/2021Wells Fargo & Company
Boost Price TargetOverweight$8.00 ➝ $11.00+17.02%
10/4/2021HC Wainwright
A. Dayal
Initiated CoverageBuy$19.00+136.61%
2/11/2020Raymond James
UpgradeUnderperform ➝ Market Perform
11/28/2018Cowen
Jason Gabelman
Set Price TargetHold$5.00+55.76%
(Data available from 10/24/2016 forward. View 10+ years of historical ratings with our analyst ratings screener.)












Calumet Specialty Products Partners (NASDAQ:CLMT) Analyst Ratings Frequently Asked Questions

What is Calumet Specialty Products Partners's consensus rating and price target?

According to the issued ratings of 3 analysts in the last year, the consensus rating for Calumet Specialty Products Partners stock is Buy based on the current 1 hold rating and 2 buy ratings for CLMT. The average twelve-month price target for Calumet Specialty Products Partners is $13.67 with a high price target of $19.00 and a low price target of $11.00. Learn more on CLMT's analyst rating history

Do Wall Street analysts like Calumet Specialty Products Partners more than its competitors?

Analysts like Calumet Specialty Products Partners stock more than the stock of other Oils/Energy companies. The consensus rating for Calumet Specialty Products Partners is Buy while the average consensus rating for oils/energy companies is Hold. Learn more on how CLMT compares to other companies

Do MarketBeat users like Calumet Specialty Products Partners more than its competitors?

MarketBeat users like Calumet Specialty Products Partners stock less than the stock of other Oils/Energy companies. 53.59% of MarketBeat users gave Calumet Specialty Products Partners an outperform vote while oils/energy companies recieve an average of 65.06% outperform votes by MarketBeat users.

Does Calumet Specialty Products Partners's stock price have much upside?

According to analysts, Calumet Specialty Products Partners's stock has a predicted upside of 44.67% based on their 12-month price targets.

What analysts cover Calumet Specialty Products Partners?

Calumet Specialty Products Partners has been rated by HC Wainwright, The Goldman Sachs Group, and Wells Fargo & Company in the past 90 days.

This page was last updated on 10/24/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.